← Back to Research Reports
CCI.US October 2, 2026

Crown Castle (CCI): 6.4% Yield on U.S. Cell Tower REIT as EPS Rebounds and Street Sees Upside

Crown Castle is a U.S. real estate investment trust that owns, operates and leases about 40,000 cell towers nationwide, providing the infrastructure that supports wireless connectivity for cities, communities and businesses. The company is based in Houston, Texas, and operates in the REIT - Specialty sector focused on specialized wireless assets. For investors, Crown Castle offers scale and defensive exposure to essential telecom infrastructure, with a market capitalization of about $28.9 billion. The shares currently trade near $66, well below the 52-week high of $95.58 and just above the 52-week low of $65.68, while analysts’ target price of $94.45 implies notable upside from current levels. The stock also carries a 6.4% dividend yield, which may appeal to income-oriented investors, although recent results show mixed fundamentals with year-over-year revenue and earnings declines and negative book value. Forward valuation at 21.2x earnings suggests the market is still paying for a recovery in earnings power, supported by expectations for EPS to improve next year.

View Fundamentals View Options

📋 Actions

No actions yet for this report.

▶

💡 Key Insights / Thesis
  • ThesisCrown Castle offers defensive exposure to essential U.S. wireless infrastructure, with about 40,000 towers and a 6.4% dividend yield — this supports an income-oriented thesis tied to recurring telecom demand
  • FinancialsTTM operating margin is 46.8% and profit margin is 20.7%, while EBITDA is about $2.7B on $4.2B of revenue — this shows the asset base can still produce strong operating cash generation
  • FinancialsRevenue fell 4.9% YoY in the latest quarter and quarterly earnings growth was down 67.5% YoY — this indicates near-term fundamentals are under pressure despite the company’s scale
  • CapitalThe balance sheet remains highly leveraged with net debt of about $29.3B and long-term debt of about $21.6B, against negative book value of -$7.68 per share — this raises the bar for equity holders and limits financial flexibility
  • ValuationThe stock trades at 27.2x trailing earnings, 21.2x forward earnings, and 12.6x EV/revenue, versus a wall street target price of $94.45 — this suggests the market is still discounting the shares relative to analyst expectations
  • CatalystAnalysts’ next-year EPS estimate rises to 2.90 from 2.31 this year, and the consensus target price implies meaningful upside from the current price near $66 — this provides a path for rerating if execution stabilizes
  • RiskReturn on equity is deeply negative at -206.7% and the shares are close to the 52-week low of $65.68 — this underscores earnings volatility, balance-sheet strain, and limited margin for disappointment
▶

🧩 Gemini